Cutaneous melanoma, the most aggressive form of skin cancer, is characterized by its accumulation of a large number of ...

The Weill Family Foundation is giving $50 million to enable 4 leading research institutions to form the Weill Cancer Hub East ...

A new study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer (TNBC) to develop ...

Sandy Weill on Thursday announced a new $50 million donation to create a cancer research and treatment hub focused on ...

Merck & Co said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy ...

Joshua Rabinowitz will direct Princeton’s role in the Weill Cancer Hub East, a collaboration with The Rockefeller University, ...

The funds will establish the Weill Cancer Hub East, a partnership among Princeton University, the Rockefeller University, Weill Cornell Medicine and the Ludwig Institute for Cancer Research aimed at ...

Recently, the research team led by Professor Zhang Zhongtao and Professor Yao Hongwei from the General Surgery Center at ...

Alan Tan, MD, discusses the 8-year follow-up data from the CheckMate 214 trial of patients with advanced renal cell carcinoma.

In this interview, News Medical speaks with Olivier Negre, Chief Scientific Officer at Smart Immune, about how immunotherapy ...

The phase 2 GIANT trial will evaluate Opdivo with or without relatlimab in IDH-wildtype newly diagnosed glioblastoma.